Tofacitinib is not a biologic

por Marren, Amy S.
Publicado 2017

Immunogenicity of biologics in inflammatory bowel disease

por Vermeire, Séverine, Gils, Ann, Accossato, Paola, Lula, Sadiq, Marren, Amy
Publicado 2018

Patient and physician preferences for ulcerative colitis treatments in the United States

por Boeri, Marco, Myers, Kelley, Ervin, Claire, Marren, Amy, DiBonaventura, Marco, Cappelleri, Joseph C, Hauber, Brett, Rubin, David T
Publicado 2019

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials

por Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Publicado 2020

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials

por Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Publicado 2020

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments

por Lee, Scott D., Shivashankar, Raina, Quirk, Daniel, Zhang, Haiying, Telliez, Jean-Baptiste, Andrews, John, Marren, Amy, Mukherjee, Arnab, Loftus, Edward V.
Publicado 2021

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis

por Mahadevan, Uma, Dubinsky, Marla C, Su, Chinyu, Lawendy, Nervin, Jones, Thomas V, Marren, Amy, Zhang, Haiying, Graham, Daniela, Clowse, Megan E B, Feldman, Steven R, Baumgart, Daniel C
Publicado 2018

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

por Clowse, Megan E. B., Feldman, Steven R., Isaacs, John D., Kimball, Alexandra B., Strand, Vibeke, Warren, Richard B., Xibillé, Daniel, Chen, Yan, Frazier, Donald, Geier, Jamie, Proulx, James, Marren, Amy
Publicado 2016

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

por Sands, Bruce E., Armuzzi, Alessandro, Marshall, John K., Lindsay, James O., Sandborn, William J., Danese, Silvio, Panés, Julián, Bressler, Brian, Colombel, Jean‐Frédéric, Lawendy, Nervin, Maller, Eric, Zhang, Haiying, Chan, Gary, Salese, Leonardo, Tsilkos, Konstantinos, Marren, Amy, Su, Chinyu
Publicado 2019

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

por Panés, Julian, Sandborn, William J, Schreiber, Stefan, Sands, Bruce E, Vermeire, Séverine, D'Haens, Geert, Panaccione, Remo, Higgins, Peter D R, Colombel, Jean-Frederic, Feagan, Brian G, Chan, Gary, Moscariello, Michele, Wang, Wenjin, Niezychowski, Wojciech, Marren, Amy, Healey, Paul, Maller, Eric
Publicado 2017